Cancer cell resistance to therapeutics can result from acquired or de novo-mediated factors. Here, we have utilised advanced breast cancer cell culture models to elucidate de novo doxorubicin resistance mechanisms. | Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins